Capecitabine Plus Oxaliplatin Compared With 5-Fluorouracil Plus Oxaliplatin in Metastatic Colorectal Cancer: Meta-Analysis of Randomized Controlled Trials

Oncology Letters - Greece
doi 10.3892/ol.2012.567
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Phase I Trial of Oxaliplatin Plus S-1 Chemotherapy in Patients With Metastatic Colorectal Cancer

Oncology Letters
Cancer ResearchOncology
2010English

Oxaliplatin Plus Irinotecan Compared With Irinotecan Alone as Second-Line Treatment After Single-Agent Fluoropyrimidine Therapy for Metastatic Colorectal Carcinoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2008English

Mitomycin C Plus 5-Fluorouracil Versus Plasmapheresis and the Same Chemotherapy in Metastatic Colorectal Cancer: A Prospective Randomized Trial

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
1986English

Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Phase II Study of Gefitinib, Fluorouracil, Leucovorin, and Oxaliplatin Therapy in Previously Treated Patients With Metastatic Colorectal Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2005English

All-Trans-Retinoic Acid (ATRA) Plus Oxaliplatin Plus 5-Fluorouracil/Leucovorin (FOLFOX) Versus FOLFOX Alone as Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma and Extrahepatic Metastasis: Study Protocol for a Randomized Controlled Trial

Trials
MedicinePharmacology
2019English

2318 Prospective Phase II Trial of Pazopanib Plus CapeOX (Capecitabine and Oxaliplatin) in Previously Untreated Patients With Advanced Gastric Cancer

European Journal of Cancer
Cancer ResearchOncology
2015English

Serum Iron Levels as a New Biomarker in Chemotherapy With Leucovorin and Fluorouracil Plus Oxaliplatin or Leucovorin and Fluorouracil Plus Irinotecan, With or Without Molecularly-Targeted Drugs

Molecular and Clinical Oncology
Cancer ResearchOncology
2013English

Cetuximab Plus Gemcitabine/Oxaliplatin (GEMOXCET) in First-Line Metastatic Pancreatic Cancer: A Multicentre Phase II Study

British Journal of Cancer
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy